Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Comprehensive outcome research with safety data and practical protocol references
From BPC-157 to MK-677, the new science of peptide-driven body recomposition is challenging the traditional anabolic toolkit.
The era of natural mimicry is here. Peptidomimetics designed to hijack endogenous signaling cascades offer accelerated tissue repair and metabolic correction — but the myostatin paradox, oncologic unknowns, and the regulatory cat-and-mouse game demand clinical caution over marketing hype.
Detailed compound profiles with mechanisms, safety data, and dosing protocols
Evidence-based supplement stacks designed to support your peptide protocols
Evidence-graded testosterone profiles by ester and formulation, with safety data and peptide alternatives
For the high-performance community, the quest for longevity has evolved beyond the basic pillars of sleep and nutrition. We have moved into the era of precision signaling—using the body's own biochemical language to accelerate tissue repair and optimize metabolic flux.
For the high-performance community, the quest for longevity has evolved beyond the basic pillars of sleep and nutrition. We have moved into the era of precision signaling—using the body's own biochemi
A selective ghrelin mimetic that triggers your pituitary to release growth hormone without touching cortisol, prolactin, or appetite.
Ipamorelin is a synthetic pentapeptide and the first truly selective growth hormone secretagogue. It binds the GHS-R1a receptor to trigger pulsatile GH release without the hormonal side-channel activation that defined earlier peptides like GHRP-6.
The biochemical cofactors your body needs to support Ipamorelin therapy.
Evidence-based supplement companion for Ipamorelin , a selective ghrelin mimetic that triggers your pituitary to release growth hormone without touching cortisol, prolactin, or appetite.
The biochemical cofactors your body needs to support CJC-1295 therapy.
Evidence-based supplement companion for CJC-1295 , a synthetic GHRH analog that tells your pituitary to release its own growth hormone, not inject someone else's.
The most prescribed testosterone ester outside the US, with a 4.5-7 day half-life that demands weekly dosing for stable levels. What the clinical data says about the hepcidin hijack, erythrocytosis, and why dosing frequency matters more than dose size.
Evidence-graded profile of testosterone enanthate: the hepcidin mechanism behind erythrocytosis, DHT and the scrotal paradox, dosing frequency pharmacokinetics, the TRAVERSE prostate saturation model, age-stratified risk, and peptide alternatives.
35+
Articles
18
Categories